The role of LXRα in promoting fatty acid and triglyceride accumulation is well established and has proved a major obstacle in the development of LXR ligands as therapeutics against metabolic and cardiovascular disorders (Hong and Tontonoz, 2014). The gene discussed is NR1H3; the disease is cardiovascular disorder.